Document is current
Any future updates will be listed below
-
Authors
Reyes, Luis Felipe
Serrano-Mayorga, Cristian C.
Zhang, Zhongheng
Tsuji, Isabela
De Pascale, Gennaro
Prieto, Valeria Enciso
Mer, Mervyn
Sheehan, Elyce
Nasa, Prashant
Zangana, Goran
Avanti, Kostoula
Tabah, Alexis
Shrestha, Gentle Sunder
Bracht, Hendrik
Fatoni, Arie Zainul
Abidi, Khalid
bin Sulaiman, Helmi
Eshwara, Vandana Kalwaje
De Bus, Liesbet
Hayashi, Yoshiro
Korkmaz, Pervin
Ait Hssain, Ali
Buetti, Niccolò
Goh, Qing Yuan
Kwizera, Arthur
Koulenti, Despoina
Nielsen, Nathan D.
Povoa, Pedro
Ranzani, Otavio
Rello, Jordi
Conway Morris, Andrew
,
,
Reyes, Luis Felipe
Zhang, Zhongheng
Mer, Mervyn
Tabah, Alexis
Kwizera, Arthur
Koulenti, Despoina
Nielsen, Nathan D.
Povoa, Pedro
Ranzani, Otavio
Rello, Jordi
Conway Morris, Andrew
,
Mphandi, Wilson
Ceccato, Adrian
Tabah, Alexis
Jahan, Ahsina
De Bus, Liesbet
Tsuji, Isabela
Zhang, Zhongheng
Reyes, Luis Felipe
Jibaja, Manuel
Alsisi, Adel
Roquilly, Antoine
Bracht, Hendrik
Arvaniti, Kostoula
Sandoval, Nancy
Eshwara, Vandana Kalwaje
Zainul, Arie
Zand, Faird
De Pascale, Gennaro
Hayashi, Yoshiro
Viderman, Dimitry
Sulaiman, Helmi bin
Lagunes, Leonel
Nasa, Prashant
Zangana, Goran
Abidi, Khalid
Shrestha, Gentle
Schouten, Jeroen
Buowari, Dabota
Hashmi, Madiha
Luque, Nestor
Nora, David
Hssain, Ali Ait
Kuzovlev, Artem
Goh, Qing Yuan
Mer, Mervyn
Rello, Jordi
Hanifa, Rashan
Sjovall, Fredrik
Buetti, Niccollò
Yeh, Tony
Korkmaz, Pervin
Kwizera, Arthur
Shaban, Nesreen
Hamed, Islam
Sheehan, Elyce
-
Funding
Funding for this research was provided by:
Universidad de La Sabana (MED-357-2023)
National Key Research and Development Program of China (2022YFC2504503)
National Natural Science Foundation of China (82272180)
Project of Drug Clinical Evaluate Research of Chinese Pharmaceutical Association (CPA-Z06-ZC-2021–004)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183865)
Medical Research Council (MR/V006118/1)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 18 November 2024
First Online: 22 November 2024
Declarations
:
: This multinational cross-sectional study conducted an online self-administered questionnaire to intensive care clinicians. As an anonymized survey of clinical practice without individual patient data, the requirement for research ethics approval and formal written consent was waived by the UK Health Research Authority.
: Not applicable.
: Nathan D. Nielsen sits on the scientific advisory boards of Adrenomed AG and Inotrem. Jordi Rello received honoraria from the Speakers' Bureau and consultancies from ROCHE, Pfizer & MSD. Andrew Conway Morris reports speaking fees from Biomerieux, Thermo-Fisher, Fischer and Paykel and Boston Scientific, he sits on the scientific advisory board of Cambridge Infection Diagnostics. Pedro Póvoa reports honoraria for lectures and advisory boards from Merck Sharp & Dohme, Gilead, Mundipharma and Pfizer, and advisory boards from Merck Sharp & Dohme, Sanofi, Gilead and Biocodex. All other authors report no competing interests.
